ALLERGAN USA, INC. for ALLERGAN USA, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
H.R. 306, Kidney Disease Education Benefits Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Budget/Appropriations BUD
Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Copyright/Patent/Trademark CPT
S. 515, H.R. 1260 Patent Reform Act of 2009 H.R. 1427, S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 623 Access to Life Saving Medicine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Medicare/Medicaid MMM
Medicare Improvement for Patients and Providers Act of 2008 (P.L. 110-275)
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Health Issues HCR
Prescrition Drug User Fees The Prescription Drug Marketing Act and issues relating to anti-counterfeiting/pedigree issues Drug importation issues Drug safety and inspection of drug manufacturing facilities H.R. 759, Food and Drug Administration Globalization Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| G THOMAS LONG | — |
| ASHLIE VAN METER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.